ISSN: 0098-8588

Journal Guideline

American Journal of Law and Medicine Q2 Unclaimed

Cambridge University Press United Kingdom

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

American Journal of Law and Medicine is a journal indexed in SJR in Medicine (miscellaneous) and Health (social science) with an H index of 34. It has a price of 3971,1 €. It has an SJR impact factor of 0,228 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0,228.

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy: Open Choice

Type of publications:

Publication frecuency: -

Categories: Law (Q2) Health (social science) (Q3) Medicine (miscellaneous) (Q4)

Price

3971,1 €

Inmediate OA

NPD

Embargoed OA

0 €

Non OA

Metrics

0,228

SJR Impact factor

34

H Index

25

Total Docs (Last Year)

82

Total Docs (3 years)

2848

Total Refs

47

Total Cites (3 years)

82

Citable Docs (3 years)

0.41

Cites/Doc (2 years)

113.92

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Clinical Rheumatology Q2
Pharmacological Reports Q2
Journal of Human Nutrition and Dietetics Q2
Diseases of the Colon and Rectum Q2
Oncology Reports Q2

Compare this journals

Aims and Scope

Best articles by citations

Tobacco Control Lessons from the Higgs Boson: Observing a Hidden Field behind Changing Tobacco Control Norms in Japan

Limiting Occupational Medical Evaluations under the Americans with Disabilities Act and the Genetic Information Nondiscrimination Act

Beyond Payment and Delivery Reform: The Individual Mandate's Cost-Control Potential

The Growing Importance of Mental Health Parity

Expansion of the Priority Review Voucher Program Under the 21st Century Cures Act: Implications for Innovation and Public Health

Face Value: Challenges of Transplant Technology Rhonda

Sex and the Surgeon's Knife: The Family Court's Dilemma ...Informed Consent and the Specter of Iatrogenic Harm to Children with Intersex Characteristics

Intelligence, Disability, and Race: Intersections and Critical Questions

Is Watson for Oncology per se Unreasonably Dangerous?: Making A Case for How to Prove Products Liability Based on a Flawed Artificial Intelligence Design

Demanding Individually Safe Drugs Today: Overcoming the Cross-Labeling Legal Hurdle to Pharmacogenomics

Selling Stem Cell Science: How Markets Drive Law along the Technological Frontier

Baby M Turns 30: The Law and Policy of Surrogate Motherhood

SHOW MORE ARTICLES

FDA Statutory Authority to Regulate the Safety of Dietary Supplements

Revisionist History? Responding to Gun Violence Under Historical Limitations

Fast-Forward to the Frightening Future: How the 21st Century Cures Act Accelerates Technological Innovation...at Unknown Risk to Us All

AIDS Activists, FDA Regulation, and the Amendment of America's Drug Constitution

"Since I Must Please Those Below"

Digital Manipulation of Images of Models' Appearance in Advertising: Strategies for Action Through Law and Corporate Social Responsibility Incentives to Protect Public Health

Cells as Drugs?: Regulating the Future of Medicine

Obamacare's Impact on Labor Markets: Limits on the Predictive Value of Romneycare

Celebrity Drug Endorsements

Silver Spoons and Golden Genes: Genetic Engineering and the Egalitarian Ethos

Epilogue: Health Care, Federalism, and Democratic Values

Supreme Court Reshapes the Landscape of False Claims Act Litigation